DuPont blueprints $23M Indian R&D center

DuPont has unveiled plans to invest almost $23 million in a new R&D center in Hyderabad, India. The site initially will focus on molecular biology, bio-informatics and polymer synthesis, according to DuPont. DuPont has appointed Homi Bhedwar as director of the Knowledge Center.

"The establishment of the DuPont Knowledge Center in India is consistent with our company's strategy of going where the growth is," said Balvinder Singh Kalsi, president, DuPont India. "Our intent is to leverage Indian science and engineering talent for the benefit of DuPont customers and shareholders."

- here's the release on the new R&D facility

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.